4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow ulodesine: new trials by email Literature Review of ulodesine trials Research Report on ulodesine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency Placebo, Ulodesine (BCX4208) 5 mg, Ulodesine (BCX4208) 10 mg - Gout, Hyperuricemia | Phase 2 | Completed | BioCryst Pharmaceuticals | 20 | 2011-09-01 | 2013-11-20 |
| Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol ulodesine, Placebo - Gout, Hyperuricemia | Phase 2 | Completed | BioCryst Pharmaceuticals | 279 | 2010-12-01 | 2013-11-20 |
| Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout Placebo, Allopurinol, BCX4208 - Gout | Phase 2 | Completed | BioCryst Pharmaceuticals | 87 | 2010-05-01 | 2012-01-23 |
| Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout placebo, BCX4208 - Gout | Phase 2 | Completed | BioCryst Pharmaceuticals | 99 | 2009-09-01 | 2012-01-23 |
Gout (4) · Hyperuricemia (4) · Arthritis (2) · Joint Diseases (2) · Renal Insufficiency (1)
United States (4)